Cargando…
Normal high-sensitivity cardiac troponin for ruling-out inpatient mortality in acute COVID-19
INTRODUCTION: Assessment of inpatient mortality risk in COVID-19 patients is important for guiding clinical decision-making. High sensitivity cardiac troponin T (hs-cTnT) is a biomarker of cardiac injury associated with a worse prognosis in COVID-19. We explored how hs-cTnT could potentially be used...
Autores principales: | Liu, Alexander, Hammond, Robert, Chan, Kenneth, Chukwuenweniwe, Chukwugozie, Johnson, Rebecca, Khair, Duaa, Duck, Eleanor, Olubodun, Oluwaseun, Barwick, Kristian, Banya, Winston, Stirrup, James, Donnelly, Peter D., Kaski, Juan Carlos, Coates, Anthony R. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121001/ https://www.ncbi.nlm.nih.gov/pubmed/37083886 http://dx.doi.org/10.1371/journal.pone.0284523 |
Ejemplares similares
-
Low CRB-65 Scores Effectively Rule out Adverse Clinical Outcomes in COVID-19 Irrespective of Chest Radiographic Abnormalities
por: Liu, Alexander, et al.
Publicado: (2023) -
Comparison of Lymphocyte–CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19
por: Liu, Alexander, et al.
Publicado: (2023) -
Characterisation of Ferritin–Lymphocyte Ratio in COVID-19
por: Liu, Alexander, et al.
Publicado: (2023) -
Troponin in early presenters to rule out myocardial infarction
por: Lowry, Matthew T H, et al.
Publicado: (2023) -
Copeptin with high-sensitivity troponin at presentation is not inferior to serial troponin measurements for ruling out acute myocardial infarction
por: Kim, Kyung Su, et al.
Publicado: (2020)